News
PROC
2.090
+53.68%
0.730
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Weekly Report: what happened at PROC last week (1118-1122)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 6d ago
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/22 10:29
Weekly Report: what happened at PROC last week (1111-1115)?
Weekly Report · 11/18 12:03
Procaps Group Receives Nasdaq Delisting Notice Due to Late Filing of Form 20-F
Barchart · 11/16 03:28
Procaps Group receives Nasdaq listing determination, will request hearing
TipRanks · 11/15 23:20
PROCAPS RECEIVES NASDAQ LISTING DETERMINATION; TO REQUEST HEARING AND FURTHER STAY PENDING HEARING
Reuters · 11/15 23:15
Procaps Group Seeks Nasdaq Resolution Amid Filing Delays
TipRanks · 11/15 22:40
Weekly Report: what happened at PROC last week (1104-1108)?
Weekly Report · 11/11 12:22
Weekly Report: what happened at PROC last week (1028-1101)?
Weekly Report · 11/04 12:17
Procaps Group’s Strategic Moves for Financial Stability
TipRanks · 11/01 20:57
Weekly Report: what happened at PROC last week (1021-1025)?
Weekly Report · 10/28 12:06
Weekly Report: what happened at PROC last week (1014-1018)?
Weekly Report · 10/21 12:01
Weekly Report: what happened at PROC last week (1007-1011)?
Weekly Report · 10/14 12:40
Procaps Group Announces Financial Restatement Plans
TipRanks · 10/10 21:57
BRIEF-Procaps Issues Shareholder Letter Update
Reuters · 10/10 21:56
Procaps Group CEO issues letter to shareholders amid independent investigation
TipRanks · 10/10 21:35
PROCAPS GROUP SA: PLAN INVOLVES EXPLORING NEW FUNDING SOURCES & OTHER STRATEGIES
Reuters · 10/10 21:26
Procaps Issues Shareholder Letter Update
Barchart · 10/10 16:26
More
Webull provides a variety of real-time PROC stock news. You can receive the latest news about Procaps Group Sa through multiple platforms. This information may help you make smarter investment decisions.
About PROC
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.